Zacks Small-Cap

Zacks Small-Cap Research coverage specifically looks to focus on small- and micro-cap companies that are under-followed or under-valued by Wall Street. Our analysts seek to indentify and report on these companies, bringing to investors a unique opportunity to invest in small-cap ideas believed to be well-positioned for future growth. Our goal is to produce high quality research for the small cap portfolio.

Grant Zeng: Grant has 8 plus years professional experience in equity research and analysis. He is currently a senior biotech analyst with Zacks Investment Research Inc. since March 2006. Before joining Zacks, Grant worked for TheStreet.com as a biotech analyst from 2005-2006. From Sept 2001 to December 2003, ...More Grant worked for China Pacific Insurance Co. as an equity/fund analyst. Grant was a healthcare equity analyst with Young & Partners, LLC from Aug 2000 to September 2001. Grant had also teaching and researching experience in pharmaceutical science. Grant obtained his MBA with a major in Finance in 2000 from McMaster University, Canada. He also holds a Master of Science in Biochemistry from the University of Western Ontario, Canada; Master of Pharmacology and Bachelor of Medicine from Second Military Medical University, China. Grant is a Chartered Financial Analyst (CFA) charter holder, and series 7, 86/87 licensed.

Ken Nagy: Ken has been a Senior Research Analyst in the Technology Sector at Zacks Investment Research since he first joined the firm in 2003. Ken’s prior analyst positions include Scudder Funds, Investor’s Bank and Trust, and Westrock Advisors. Mr. Nagy has been quoted in such publications as Forbes, Bloomberg, Reuters, CNN Money and Yahoo Finance. Ken’s education includes a Masters degree in Finance from Northeastern University, and a Bachelor of Arts in Accounting from Assumption College. He holds the Chartered Financial Analyst (CFA) designation and is a member of the Boston Security Analysts Society and the CFA Institute.